ACTG

Acacia Research Corporation

55
Fundamentals42/ 100
Valuation50/ 100
Upside potential55/ 100
Risk potential18/ 100

ACTG has lower modeled downside risk, despite its lower overall score.

RKLB

Rocket Lab USA, Inc.

56
Fundamentals66/ 100
Valuation50/ 100
Upside potential66/ 100
Risk potential46/ 100

RKLB has a slight edge over ACTG overall, supported by stronger fundamentals and stronger modeled upside.

ACTG Fundamentals

MetricStatus
Stable
Weak
Healthy
Strong

ACTG's cash flow and balance sheet are currently healthy, and its revenue is stable, but its profitability is weak.

RKLB Fundamentals

MetricStatus
Strong
Under pressure
Weak
Unavailable

RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.

ACTG PE Valuation

ACTG has no meaningful PE right now: it lost money over the past year.

RKLB PE Valuation

RKLB has no meaningful PE right now: it lost money over the past year.

ACTG Forward outlook

MetricOutlook
--
Losses shrinking
Growth
Strongly improving
Limited
High

Analysts expect ACTG's losses to shrink, with revenue growing.

RKLB Forward outlook

MetricOutlook
--
Losses shrinking
Strong growth
Strongly improving
Limited
Low

Analysts expect RKLB's losses to shrink, with revenue growing. However, they disagree widely on these estimates.

ACTG Risk to reward

ScenarioChangePrice
Upside+22%$5.09
Downside-18%$3.40

Calculated from the latest close: $4.16 on Nov 12.

ACTG trails RKLB on modeled risk to reward, with less potential upside relative to its potential downside.

RKLB Risk to reward

ScenarioChangePrice
Upside+88%$120.71
Downside-46%$34.64

Calculated from the latest close: $64.07 on Nov 12.

RKLB has a better modeled risk to reward balance than ACTG, with more potential upside relative to its potential downside.

ACTG Earnings Per Share

Q4 2023: $0.58Q1 2024: $0.65Q2 2024: $0.93Q3 2024: $0.82Q4 2024: $-0.36Q1 2025: $-0.11Q2 2025: $-0.06Q3 2025: $0.05Q4 2025: $0.22Q1 2026: $-0.19Q2 2026: $-0.16Q3 2026: $-0.19
Q4 2023: $0.58Q1 2024: $0.65Q2 2024: $0.93Q3 2024: $0.82Q4 2024: $-0.36Q1 2025: $-0.11Q2 2025: $-0.06Q3 2025: $0.05Q4 2025: $0.22Q1 2026: $-0.19Q2 2026: $-0.16Q3 2026: $-0.19
QuarterTTM EPSYoY
Q3 2026-$0.19-480%
Q2 2026-$0.16-$0.10
Q1 2026-$0.19-$0.08
Q4 2025$0.22+$0.58
Q3 2025$0.05-94%
Q2 2025-$0.06-106%
Q1 2025-$0.11-117%
Q4 2024-$0.36-162%

ACTG has swung to a loss: it lost $0.19 per share over the past year, after a profit the year before.

RKLB Earnings Per Share

Q4 2023: $-0.38Q1 2024: $-0.37Q2 2024: $-0.35Q3 2024: $-0.37Q4 2024: $-0.38Q1 2025: $-0.41Q2 2025: $-0.46Q3 2025: $-0.39Q4 2025: $-0.37Q1 2026: $-0.32Q2 2026: $-0.27Q3 2026: $-0.36
Q4 2023: $-0.38Q1 2024: $-0.37Q2 2024: $-0.35Q3 2024: $-0.37Q4 2024: $-0.38Q1 2025: $-0.41Q2 2025: $-0.46Q3 2025: $-0.39Q4 2025: $-0.37Q1 2026: $-0.32Q2 2026: $-0.27Q3 2026: $-0.36
QuarterTTM EPSYoY
Q3 2026-$0.36+$0.03
Q2 2026-$0.27+$0.19
Q1 2026-$0.32+$0.09
Q4 2025-$0.37+$0.01
Q3 2025-$0.39-$0.02
Q2 2025-$0.46-$0.11
Q1 2025-$0.41-$0.04
Q4 2024-$0.38$0.00

RKLB has the edge over ACTG on earnings, with more consistent year-over-year improvement.

ACTG Quarterly Revenue

Q4 2023: $92MQ1 2024: $24MQ2 2024: $26MQ3 2024: $23MQ4 2024: $49MQ1 2025: $124MQ2 2025: $51MQ3 2025: $59MQ4 2025: $50MQ1 2026: $54MQ2 2026: $115MQ3 2026: $54M
Q4 2023: $92MQ1 2024: $24MQ2 2024: $26MQ3 2024: $23MQ4 2024: $49MQ1 2025: $124MQ2 2025: $51MQ3 2025: $59MQ4 2025: $50MQ1 2026: $54MQ2 2026: $115MQ3 2026: $54M
QuarterRevenueYoY
Q3 2026$54.4M-8.4%
Q2 2026$114.6M+124%
Q1 2026$54.2M-56%
Q4 2025$50.1M+2.6%
Q3 2025$59.4M+155%
Q2 2025$51.2M+98%
Q1 2025$124.4M+412%
Q4 2024$48.8M-47%

ACTG's revenue fell from its 2025 peak and has held roughly level since: $54M last quarter, down 8.4% from the same quarter a year ago.

RKLB Quarterly Revenue

Q4 2023: $60MQ1 2024: $93MQ2 2024: $106MQ3 2024: $105MQ4 2024: $132MQ1 2025: $123MQ2 2025: $144MQ3 2025: $155MQ4 2025: $180MQ1 2026: $200MQ2 2026: $234MQ3 2026: $268M
Q4 2023: $60MQ1 2024: $93MQ2 2024: $106MQ3 2024: $105MQ4 2024: $132MQ1 2025: $123MQ2 2025: $144MQ3 2025: $155MQ4 2025: $180MQ1 2026: $200MQ2 2026: $234MQ3 2026: $268M
QuarterRevenueYoY
Q3 2026$267.8M+73%
Q2 2026$234.1M+62%
Q1 2026$200.3M+63%
Q4 2025$179.7M+36%
Q3 2025$155.1M+48%
Q2 2025$144.5M+36%
Q1 2025$122.6M+32%
Q4 2024$132.4M+121%

RKLB has the edge over ACTG on sales, with more consistent year-over-year improvement.

ACTG Free Cash Flow

Q4 2023: −$5MQ1 2024: $55MQ2 2024: −$127MQ3 2024: −$3MQ4 2024: −$24MQ1 2025: $335,000Q2 2025: $50MQ3 2025: $10MQ4 2025: $13MQ1 2026: $3MQ2 2026: $4MQ3 2026: $15M
Q4 2023: −$5MQ1 2024: $55MQ2 2024: −$127MQ3 2024: −$3MQ4 2024: −$24MQ1 2025: $335,000Q2 2025: $50MQ3 2025: $10MQ4 2025: $13MQ1 2026: $3MQ2 2026: $4MQ3 2026: $15M
QuarterFree cash flowYoY
Q3 2026$15M+57%
Q2 2026$3.9M-92%
Q1 2026$3.4M+916%
Q4 2025$13.2M+$36.7M
Q3 2025$9.5M+$12.4M
Q2 2025$50.1M+$176.9M
Q1 2025$335K-99%
Q4 2024-$23.6M-$19M

ACTG has the edge over RKLB on cash generation, producing positive trailing cash flow while its opponent burns cash.

RKLB Free Cash Flow

Q4 2023: −$53MQ1 2024: −$22MQ2 2024: −$28MQ3 2024: −$42MQ4 2024: −$24MQ1 2025: −$83MQ2 2025: −$55MQ3 2025: −$69MQ4 2025: −$114MQ1 2026: −$77MQ2 2026: −$110MQ3 2026: −$24M
Q4 2023: −$53MQ1 2024: −$22MQ2 2024: −$28MQ3 2024: −$42MQ4 2024: −$24MQ1 2025: −$83MQ2 2025: −$55MQ3 2025: −$69MQ4 2025: −$114MQ1 2026: −$77MQ2 2026: −$110MQ3 2026: −$24M
QuarterFree cash flowYoY
Q3 2026-$23.9M+$45.5M
Q2 2026-$110.1M-$54.8M
Q1 2026-$77.4M+$5.5M
Q4 2025-$114.2M-$90.2M
Q3 2025-$69.4M-$27.5M
Q2 2025-$55.3M-$26.9M
Q1 2025-$82.9M-$61.1M
Q4 2024-$23.9M+$28.7M

RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.

ACTG Total Shares

Q4 2023: 92MQ1 2024: 100MQ2 2024: 100MQ3 2024: 100MQ4 2024: 99MQ1 2025: 97MQ2 2025: 96MQ3 2025: 96MQ4 2025: 97MQ1 2026: 96MQ2 2026: 98MQ3 2026: 98M
Q4 2023: 92MQ1 2024: 100MQ2 2024: 100MQ3 2024: 100MQ4 2024: 99MQ1 2025: 97MQ2 2025: 96MQ3 2025: 96MQ4 2025: 97MQ1 2026: 96MQ2 2026: 98MQ3 2026: 98M
PeriodChange %Net change
Quarterly-0.5%-531K shares
1 year+1.2%+1.1M shares
3 years-1.5%-1.5M shares
5 years+101%+49M shares
Available history+79%+43.2M shares

ACTG has the edge over RKLB on shareholder dilution, with a more favorable share count trend.

RKLB Total Shares

Q4 2023: 482MQ1 2024: 490MQ2 2024: 494MQ3 2024: 498MQ4 2024: 496MQ1 2025: 506MQ2 2025: 515MQ3 2025: 529MQ4 2025: 531MQ1 2026: 605MQ2 2026: 630MQ3 2026: 652M
Q4 2023: 482MQ1 2024: 490MQ2 2024: 494MQ3 2024: 498MQ4 2024: 496MQ1 2025: 506MQ2 2025: 515MQ3 2025: 529MQ4 2025: 531MQ1 2026: 605MQ2 2026: 630MQ3 2026: 652M
PeriodChange %Net change
Quarterly+3.6%+22.6M shares
1 year+23%+124M shares
3 years+35%+168M shares
5 years+46%+204M shares

RKLB has 652M diluted shares, up 23% from a year ago.

ACTG Net Leverage

Q4 2023: -10.5xQ1 2024: -10.7xQ2 2024: -5.9xQ3 2024: -4.6xQ4 2024: -246.8xQ1 2025: -3.5xQ2 2025: -4.9xQ3 2025: -4.3xQ4 2025: -4.3xQ1 2026: -222.7xQ2 2026: -12.8xQ3 2026: -15.9x
Q4 2023: -10.5xQ1 2024: -10.7xQ2 2024: -5.9xQ3 2024: -4.6xQ4 2024: -246.8xQ1 2025: -3.5xQ2 2025: -4.9xQ3 2025: -4.3xQ4 2025: -4.3xQ1 2026: -222.7xQ2 2026: -12.8xQ3 2026: -15.9x
QuarterNet LeverageStatus
Q3 2026-15.9xNet Cash
Q2 2026-12.8xNet Cash
Q1 2026-222.7xNet Cash
Q4 2025-4.3xNet Cash
Q3 2025-4.3xNet Cash
Q2 2025-4.9xNet Cash
Q1 2025-3.5xNet Cash
Q4 2024-246.8xNet Cash

ACTG has more cash than debt.

RKLB Net Leverage

RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

ACTG Weekly Momentum

MetricValueStatus
RSI41.6Neutral
Stochastic22.5Neutral

ACTG's weekly RSI is 42 (neutral) and its Stochastic is 23 (neutral).

RKLB Weekly Momentum

MetricValueStatus
RSI46.8Neutral
Stochastic27.6Neutral

RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).

ACTG PE vs Industrials Sector

MetricACTGSector medianRelative
PEN/A24x—

ACTG has no meaningful PE right now: it lost money over the past year.

RKLB PE vs Industrials Sector

RKLB has no meaningful PE right now: it lost money over the past year.

ACTG Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$4.262.3% below
20 week MA$4.446.3% below
50 week MA$4.415.7% below
100 week MA$4.043% above
200 week MA$4.190.7% below

ACTG's trend is mixed: it's above one of its five weekly moving averages, and 0.7% below its 200-week average.

RKLB Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$61.44.3% above
20 week MA$68.15.9% below
50 week MA$77.617% below
100 week MA$56.513% above
200 week MA$31.4104% above

RKLB has the edge over ACTG on trend strength, trading above more of its moving averages.

ACTG Yearly ROI

YearStart priceEnd priceROI
2020$2.67$4.10+54%
2021$4.10$5.23+28%
2022$5.23$3.98-24%
2023$3.98$3.92-1.5%
2024$3.92$4.37+11%
2025$4.37$3.73-15%
2026 YTD$3.73$4.16+12%

ACTG has the edge over RKLB on returns for 2026, with the stronger performance.

RKLB Yearly ROI

YearStart priceEnd priceROI
2020$9.82$10.3+4.9%
2021$10.3$12.0+17%
2022$12.0$3.77-69%
2023$3.77$5.53+47%
2024$5.53$27.2+392%
2025$27.2$70.7+160%
2026 YTD$70.7$64.1-9.3%

RKLB's yearly returns have swung widely, from +392% in 2024 to −69% in 2022. It's down 9.3% so far in 2026.

Give your agent the market.

Get API key